Citizens Financial Group
CFG
$63.36
-0.11%
Citizens Financial Group is a Providence, Rhode Island-based bank holding company operating through two reportable segments — Consumer Banking and Commercial Banking — offering deposits, mortgage and home equity lending, credit cards, small business and education loans, point-of-sale finance, and wealth management to individuals, small businesses, middle-market companies, and institutions across a branch and ATM network. With roughly 17,400 employees and a market capitalization near $25 billion, CFG is a large-cap regional bank that sits in the second tier behind the money-center giants, competing primarily on regional deposit density in the Northeast and Midwest and on middle-market commercial relationships rather than on capital-markets scale or national brand reach. The current investor debate centers on net interest margin recovery and credit normalization: the quarterly progression shows revenue climbing from $2.90 billion in Q1 2025 to $3.20 billion in Q2 2026 with net income rising from $373 million to $587 million over the same span, evidence of improving profitability that bulls argue is underappreciated at a sub-1x book multiple. Bears counter that the stock's 12.5% three-month decline and 15.2 points of relative underperformance versus the S&P 500 reflect concerns about deposit costs, commercial real estate exposure, and a flattening earnings trajectory, while the broader regional bank narrative — echoed in peer commentary such as KeyCorp's raised 2026 revenue outlook — hinges on whether loan growth and margin expansion can offset credit headwinds.…
CFG
Citizens Financial Group
$63.36
Related headlines
Investment Opinion: Should I buy CFG Today?
The synthesized recommendation is a Hold with a bias toward accumulating on weakness. The core thesis is that CFG is a fundamentally improving regional bank trading below book value (0.96x) with a 23.6% upside to the analyst average target of $78.29, but near-term momentum and credit concerns warrant patience. The consensus rating of 'buy' (mean 1.55) from 19 analysts, with even the lowest target at $70.00 (10.5% above current), suggests the selloff is overdone, but the absence of recent upgrades means a catalyst is needed to close the gap.
Supporting evidence includes the forward PE of 9.74x versus the trailing 14.98x, implying 54% EPS growth to $5.74, and a PEG ratio of 0.529 that signals undervaluation relative to growth. Revenue grew 6.25% year-over-year in Q2 2026 to $3.195 billion, with net margin expanding to 18.37% from 14.50% a year earlier, and free cash flow TTM of $2.353 billion provides a 9.3% FCF yield. The dividend yield of 3.52% is well covered by a 48.5% payout ratio, and the stock trades at a discount to the typical regional bank peer range of 1.0x-1.5x book. However, ROE of 6.96% remains below the mid-teens benchmark, and the 12.5% three-month decline reflects market skepticism.
The biggest risks are a deterioration in credit quality (particularly commercial real estate), a slowdown in net interest margin expansion, and a failure to achieve the $5.74 forward EPS estimate. The rating would upgrade to Buy if the stock holds the $62.50 support and Q3 earnings show margin expansion and stable credit, or if the price-to-book ratio falls below 0.85x. It would downgrade to Sell if revenue growth decelerates below 3% or if credit costs rise significantly, pushing ROE below 6%. Relative to its history and peers, CFG appears undervalued on a forward basis but fairly valued on a trailing basis, with the market pricing in both optimism and caution.
Sign up to view all
CFG 12-Month Price Forecast
The forward-looking view is neutral with a medium confidence level, balancing the strong fundamental margin recovery against near-term momentum breakdown and credit concerns. The stock's 23.6% upside to the analyst average target and 0.96x book valuation suggest it is undervalued, but the 12.5% three-month decline and 15.16-point relative underperformance indicate the market is pricing in risks that may not be fully reflected in consensus estimates. The key tension is whether the $5.74 forward EPS is achievable; if Q3 earnings show continued margin expansion and stable credit, the stock could re-rate toward $78, but any miss could push it toward the $48-$63 bear range. I would upgrade to bullish if the stock breaks above $70 resistance with volume and Q3 results confirm margin expansion, and downgrade to bearish if it breaks below $62.50 support or if credit provisions rise significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Citizens Financial Group's 12-month outlook, with a consensus price target around $78.03 and implied upside of +23.1% versus the current price.
Average Target
$78.03
0 analysts
Implied Upside
+23.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $89
Analyst target range
Coverage is robust with 19 analysts, and the consensus is decisively bullish: the recommendation is "buy" with a mean rating of 1.55 (where 1.0 is a strong buy and 5.0 a strong sell), and the average target price of $78.29 implies 23.6% upside from the current $63.36. That is a striking disconnect — the stock has fallen 12.5% over three months while the consensus target sits 23.6% above the current price, suggesting analysts view the selloff as a buying opportunity rather than a fundamental deterioration. The institutional ratings log reinforces this: of the ten most recent actions, seven are Outperform/Overweight/Buy (Morgan Stanley, Cantor Fitzgerald, JP Morgan, Citigroup, RBC, Evercore ISI, KBW) and only three are Hold/Neutral (Truist twice, Baird), with no downgrades to Sell and no changes in rating direction — every action is a reiteration, indicating stable conviction rather than fresh catalysts. The target range of $70.00 to $89.00 is moderately wide at roughly 27% of the midpoint, signaling meaningful dispersion in assumptions. The high target of $89.00 (40.5% above the current price) would require multiple expansion toward 1.3x-1.4x book alongside the forward EPS of $5.74, implying the market re-rates CFG as a higher-quality franchise with ROE climbing toward 10%+ and credit costs staying benign. The low target of $70.00 (still 10.5% above the current price) is notable because even the most cautious analyst sees upside — it prices in margin compression or modest credit deterioration but not a recessionary scenario, which is a strong signal about the downside floor. The consensus forward EPS of $5.74 (range $5.67-$5.81, a tight 2.4% spread) shows high confidence in near-term earnings, and the revenue estimate of $7.235 billion (range $7.169-$7.299 billion) is similarly tight; the uncertainty is therefore in the multiple, not the earnings. With a 4.29-day short ratio and a stock trading 15.9% below its 52-week high while analysts uniformly reiterate bullish ratings, the setup favors a mean-reversion trade toward the $70-$75 zone, though the absence of any recent upgrade means a positive catalyst — likely a Q3 earnings beat or favorable net interest margin guidance — is needed to close the gap to the $78.29 consensus.
Drowning in data?
Find the real signal!
Bulls vs Bears: CFG Investment Factors
The bull case rests on improving profitability (net margin up 549 basis points year-over-year), a discounted 0.96x book valuation, and a 23.6% analyst target upside, while the bear case highlights recent momentum breakdown (-12.5% over three months), low ROE (6.96%), and valuation near historical upper bands. Currently, the bear evidence has stronger near-term weight due to the persistent downtrend and relative underperformance, but the fundamental margin recovery and analyst consensus suggest the selloff may be overdone. The single most important tension is whether net interest margin expansion and credit quality can sustain the earnings growth implied by the $5.74 forward EPS estimate; if they do, the stock could re-rate toward book value and the $78 average target, but if credit costs rise or deposit competition intensifies, the 0.96x book multiple could compress further.
Bullish
- Margin expansion drives earnings growth: Net margin expanded from 12.88% in Q1 2025 to 18.37% in Q2 2026, while gross margin rose from 61.53% to 67.26% and operating margin from 16.16% to 23.63%. This operating leverage is the strongest fundamental trend, with net income growing from $373 million to $587 million over the same period.
- Deep discount to book value: CFG trades at a price-to-book ratio of 0.957, below tangible book value, which is unusual for a profitable bank with a 3.52% dividend yield and 6.96% ROE. Regional bank peers typically trade at 1.0x-1.5x book, implying a 4%-36% discount that could narrow as profitability improves.
- Analyst consensus sees 23.6% upside: With 19 analysts covering the stock, the consensus rating is 'buy' (mean 1.55) and the average target price of $78.29 implies 23.6% upside from $63.36. Even the lowest target of $70.00 is 10.5% above the current price, suggesting a strong downside floor.
- Attractive forward valuation: The forward PE of 9.74x is well below the trailing PE of 14.98x, reflecting expected EPS growth to $5.74. The PEG ratio of 0.529 is far below 1.0, indicating the stock is cheap relative to its growth prospects, and the FCF yield of roughly 9.3% ($2.353 billion TTM FCF) is compelling.
Bearish
- Recent momentum breakdown: The stock has fallen 12.47% over three months and 5.21% over the past month, underperforming the S&P 500 by 15.16 and 6.43 percentage points respectively. The 15.9% drawdown from the 52-week high of $75.33 signals distribution and eroding relative strength.
- Low ROE signals efficiency issues: ROE of 6.96% and ROA of 0.94% are well below the mid-teens ROE aspirational benchmark for regional banks. This suggests the bank is not generating sufficient returns on its equity base, which may justify the sub-1x book valuation and limit multiple expansion.
- Valuation near historical upper band: The price-to-book ratio of 0.957 is near the top of its multi-year range of 0.53x-0.87x seen in 2023-2024, and the trailing PE of 14.98x is near the upper end of its recent 11x-13.5x band. Further multiple expansion requires ROE improvement or sector re-rating.
- Credit and deposit cost concerns: The stock's underperformance likely reflects worries about commercial real estate exposure and deposit costs, as evidenced by the flattening earnings trajectory and the 12.5% three-month decline. The Q4 2025 revenue presentation quirk ($2.157 billion) also adds uncertainty to trend analysis.
CFG Technical Analysis
CFG is in a medium-term downtrend within a longer-term recovery, a split personality that defines the current setup. The stock is up 30.94% over the past year and 6.68% year-to-date, yet it has fallen 12.47% over three months and 5.21% over the past month, leaving the current price of $63.36 at roughly 54.7% of its 52-week range of $48.305 to $75.33. That positioning — closer to the midpoint than to either extreme — signals a stock that has surrendered its momentum premium but has not yet reached value territory; the 52-week high of $75.33 was set in mid-August, and the subsequent 15.9% drawdown from that peak (consistent with the reported -18.32% max drawdown) marks a clear distribution phase rather than a healthy consolidation. The 1-year gain of 30.94% versus the S&P 500's 15.53% still leaves 15.41 points of relative strength over twelve months, but that outperformance is being steadily eroded. Recent momentum is decisively negative and diverging from the longer-term trend: the 1-month change of -5.21% compares with the S&P 500's +1.22% over the same period, a 6.43-point relative shortfall, while the 3-month relative strength of -15.16 points is even worse. The sequence of lower highs is visible in the price data — $74.73 on August 14, $70.83 on September 3, $70.54 on September 14, and a sharp gap to $66.84 on September 16 — followed by a grind down to the $62.57-$64.09 zone in October. Volume of 9.45 million shares on the latest session is unremarkable, and with no RSI provided, the price action alone suggests the stock is approaching oversold conditions but has not yet printed a capitulation or reversal signal; the short ratio of 4.29 days-to-cover indicates moderate short interest that could fuel a squeeze on any positive catalyst. Key levels are well defined: support sits at the 52-week low of $48.305, with an intermediate floor around the $62.50-$63.00 area where the stock has repeatedly found buyers in October, while resistance is the 52-week high of $75.33, with a nearer ceiling at the $70-$71 breakdown zone from September. A breakout above $70 would signal that the August-September distribution was a shakeout and re-open the path toward the highs, whereas a decisive break below $62.50 would target the $58-$60 region and confirm the downtrend. The beta of 1.062 means CFG is only about 6% more volatile than the market — modest for a regional bank — so position sizing need not be dramatically reduced, but the 18.32% max drawdown shows the stock can still deliver meaningful pain in a sector rotation; traders should size positions around the $62.50 support rather than the $75 resistance.
Beta
1.06
1.06x market volatility
Max Drawdown
-18.3%
Largest decline past year
52-Week Range
$49-$75
Price range past year
Annual Return
+30.9%
Cumulative gain past year
| Period | CFG Return | S&P 500 |
|---|---|---|
| 1m | -5.2% | +0.2% |
| 3m | -12.5% | +2.9% |
| 6m | -1.7% | +8.4% |
| 1y | +30.9% | +14.9% |
| ytd | +6.7% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CFG Fundamental Analysis
Revenue is on a clear upward trajectory with accelerating year-over-year growth. Q2 2026 revenue of $3.195 billion grew 6.25% year-over-year versus $3.007 billion in Q2 2025, and the sequential path — $2.896 billion in Q1 2025, $3.007 billion in Q2 2025, $3.088 billion in Q3 2025, $2.157 billion in Q4 2025 (a quarter with a different reporting presentation), $3.026 billion in Q1 2026, and $3.195 billion in Q2 2026 — shows a steady climb interrupted only by the Q4 accounting quirk. Segment data for the latest period shows Consumer Banking generating $1.608 billion and Commercial Banking $719 million, with a -$159 million "Other" drag, meaning the consumer franchise is the dominant growth engine at roughly 69% of segment revenue. The 6.25% growth rate is respectable for a regional bank but not spectacular; it implies the investment case rests more on margin and credit quality than on top-line acceleration, and the consensus revenue estimate of $7.235 billion for the forward period suggests analysts expect continued mid-single-digit expansion. Profitability is solid and improving. Q2 2026 net income of $587 million on $3.195 billion of revenue produced a net margin of 18.37%, up from 14.50% in Q2 2025 and 12.88% in Q1 2025, while the gross margin of 67.26% (up from 62.29% a year earlier) and operating margin of 23.63% (up from 18.42%) confirm genuine operating leverage. The net income ratio progression — 12.88% → 14.50% → 16.00% → 24.48% → 17.09% → 18.37% — shows margins expanding materially over six quarters, and the 16.42% trailing net margin and 20.88% operating margin in the valuation data corroborate the trend. For a regional bank, a 67% gross margin and 18% net margin are healthy, and the improvement trajectory is the single strongest fundamental argument in the bull case. Balance sheet and cash flow metrics are adequate but require nuance. The debt-to-equity ratio of 0.4287 is moderate for a bank, and the current ratio of 1.043 reflects the liquid-but-levered nature of bank balance sheets; ROE of 6.96% and ROA of 0.94% are below what a well-run regional bank should earn (mid-teens ROE is the aspirational benchmark), which is the core efficiency problem. Free cash flow TTM of $2.353 billion against a $25.2 billion market cap implies an FCF yield of roughly 9.3%, which is attractive, though quarterly FCF is highly volatile ($705 million in Q2 2026, $237 million in Q1 2026, -$250 million in Q4 2025) due to investment portfolio churn. The dividend yield of 3.52% with a payout ratio of 48.5% is well covered, and the company repurchased $225 million of stock in Q2 2026 while paying $231 million in dividends, signaling confidence in capital adequacy; cash on hand of $12.76 billion provides ample liquidity, so external financing dependence is low.
Quarterly Revenue
$3.2B
2026-06
Revenue YoY Growth
+6.3%
YoY Comparison
Gross Margin
67.3%
Latest Quarter
Free Cash Flow
$2.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CFG Overvalued?
Because CFG is profitable — Q2 2026 net income of $587 million and trailing EPS of $1.31 — the PE ratio is the appropriate primary metric, and here the story is compelling: the trailing PE of 14.98x drops to a forward PE of 9.74x, a 35% compression that implies the market expects earnings to grow substantially. That gap is corroborated by the consensus EPS estimate of $5.74 for the forward period, which against the $63.36 price yields the 9.74x forward multiple; the market is pricing in roughly 54% EPS growth from the trailing base, a demanding but not implausible expectation given the margin expansion trajectory. The PEG ratio of 0.529 is the standout data point — well below 1.0, it suggests the stock is cheap relative to its expected growth rate, though bank PEG ratios should be treated with caution given earnings cyclicality. On peer comparison, the valuation data does not provide a direct industry average, but the internal evidence is telling: a price-to-book ratio of 0.957 means CFG trades below tangible book value, a level that for a profitable, dividend-paying regional bank with 6.96% ROE typically signals either deep value or embedded credit concerns. The PS ratio of 2.26 and EV/EBITDA of 8.46 are moderate, while the PCF ratio of 11.40 and EV/Sales of 3.84 sit in reasonable territory; against a regional bank peer group that generally trades at 1.0x-1.5x book, CFG's 0.96x is a discount of roughly 4% to 36%, which is difficult to justify given its improving margins unless the market is discounting commercial real estate exposure or deposit franchise erosion. Historical context sharpens the picture. CFG's own PE history over the past several years shows a range from roughly 7.0x (Q2 2023) to 24.4x (Q4 2023, a depressed-earnings quarter), with the stock spending most of 2024-2025 in the 11x-13.5x band; the current trailing PE of 14.98x is near the upper end of that recent range, but the forward PE of 9.74x is near the low end, meaning the market is simultaneously paying a premium on trailing earnings and a discount on forward earnings. The price-to-book history is more instructive: CFG traded at 0.53x-0.87x book through 2023-2024 and has re-rated to 0.96x now, near the top of its multi-year band — the market has already rewarded the margin recovery, so further multiple expansion requires either ROE improvement toward double digits or a re-rating of the entire regional bank sector.
PE
15.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the bank's low profitability and earnings quality. ROE of 6.96% and ROA of 0.94% are well below peer benchmarks, indicating inefficient capital deployment and limited organic capital generation. The forward EPS estimate of $5.74 implies 54% growth from the trailing $1.31, a demanding target that relies heavily on continued margin expansion; any slowdown in net interest margin or increase in provisions could derail this trajectory. Additionally, quarterly free cash flow is highly volatile ($705 million in Q2 2026, $237 million in Q1 2026, -$250 million in Q4 2025), reflecting investment portfolio churn and potential liquidity mismatches. The debt-to-equity ratio of 0.43 is moderate, but the bank's current ratio of 1.04 leaves little room for unexpected funding pressures.
Market and competitive risks include valuation compression and sector rotation. CFG's price-to-book of 0.957 is near the top of its historical range, and the trailing PE of 14.98x is above its recent 11x-13.5x band, leaving limited room for multiple expansion without further ROE improvement. The beta of 1.062 means the stock is only 6% more volatile than the market, but regional banks are highly sensitive to interest rate changes and credit cycles; a flattening yield curve or rising deposit costs could compress margins. Competitive pressures from larger money-center banks and fintech disruptors in consumer lending could erode market share, particularly in the consumer segment that generates 69% of revenue. Recent peer commentary from KeyCorp raising its 2026 revenue outlook highlights sector optimism, but CFG's own 12.5% three-month decline suggests company-specific concerns about credit quality or deposit franchise.
The worst-case scenario would involve a combination of rising credit costs (particularly in commercial real estate), deposit outflows, and a slowdown in loan growth, leading to earnings misses and multiple compression. In this scenario, the stock could retest its 52-week low of $48.305, representing a 23.8% decline from the current price of $63.36. The analyst low target of $70.00 is still above the current price, but in a severe recession, the stock could fall below that level toward the 2023-2024 book value range of 0.53x-0.87x, implying a price of $35-$58. A realistic downside of -24% to the 52-week low is plausible if credit conditions deteriorate, and the max drawdown of -18.32% shows the stock can deliver significant pain in a sector rotation.
FAQ
The most severe risk is credit deterioration, particularly in commercial real estate, which could force large provisions and push the stock toward its 52-week low of $48.305 (-23.8%). Financial risk is elevated by the low ROE of 6.96% and ROA of 0.94%, which are below peer benchmarks and limit capital generation. Competitive and market risks include valuation compression, as the price-to-book of 0.957 is near historical highs, and sector rotation out of regional banks due to interest rate sensitivity (beta 1.062). Company-specific risk centers on the demanding forward EPS estimate of $5.74, which requires 54% growth; any miss could trigger a re-rating. Additionally, deposit cost pressures and a flattening yield curve could compress net interest margin, undermining the earnings recovery.
The 12-month forecast has three scenarios: a bull case (30% probability) targeting $78-$89, driven by margin expansion and ROE improvement toward 10%; a base case (50% probability) targeting $70-$78, assuming gradual margin improvement and stable credit; and a bear case (20% probability) targeting $48-$63, reflecting a recession or credit deterioration. The base case is most likely, with the stock recovering toward the analyst average target of $78.29 as earnings grow in line with the $5.74 EPS estimate. The key assumption is that net interest margin expands modestly and credit costs remain stable, allowing the stock to break above $70 resistance and re-rate toward book value.
CFG appears undervalued on a forward basis but fairly valued on a trailing basis. The price-to-book ratio of 0.957 is below the typical regional bank range of 1.0x-1.5x, and the forward PE of 9.74x is well below the trailing 14.98x, implying expected EPS growth to $5.74. The PEG ratio of 0.529 is far below 1.0, indicating the stock is cheap relative to its growth rate. However, the trailing PE of 14.98x is near the upper end of its recent 11x-13.5x band, and the price-to-book is near the top of its 2023-2024 range of 0.53x-0.87x. The market is pricing in optimism about margin recovery but also caution about credit risks, leaving the stock in a fair value zone with a slight undervaluation on forward metrics.
CFG presents a mixed risk/reward profile. On the positive side, the stock trades at 0.96x book value, below the peer range of 1.0x-1.5x, and offers a 23.6% upside to the analyst average target of $78.29, with a forward PE of 9.74x and a PEG ratio of 0.529 suggesting undervaluation. However, the stock has fallen 12.5% over three months and underperformed the S&P 500 by 15.16 percentage points, reflecting concerns about credit quality and deposit costs. The biggest downside risk is a retest of the 52-week low of $48.305, a 23.8% decline, if commercial real estate losses mount. For value-oriented investors with a medium-term horizon and tolerance for sector volatility, CFG could be a good buy on stabilization above $62.50, but momentum-focused investors should wait for a breakout above $70.
CFG is more suitable for medium-to-long-term investment (12-24 months) than short-term trading. The stock's beta of 1.062 indicates moderate volatility, but the 18.32% max drawdown and 12.5% three-month decline show it can deliver significant short-term pain. The 3.52% dividend yield and 48.5% payout ratio provide income support for long-term holders, while the forward PE of 9.74x and 0.96x book value offer valuation upside. However, the low ROE of 6.96% and earnings cyclicality mean the stock is not a stable compounder. Short-term traders could play the range between $62.50 support and $70 resistance, but a minimum holding period of 12 months is recommended to capture the margin recovery and potential re-rating toward the $78 average target.
